We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Hits Texas Drug Facility for Oversight of Pilot/Exhibit Batches
FDA Hits Texas Drug Facility for Oversight of Pilot/Exhibit Batches
The FDA cited Sovereign Pharmaceuticals for quality and other failures observed during a Dec. 11-19 inspection of its facility in Fort Worth, Texas—including its failure to ensure the quality of pilot or exhibit batches.